Five patents currently held, every record listed here
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Mar 2028. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
3
Ending by 2030
Mar 2028
Next term end
4
Patent families
When these terms end
Each bar runs from grant to computed term end. 2012 to 2034.
US 8,480,647
Delivery Device for Delivering Bioactive Agents to Internal Tissue in a Body
Jul 31, 2030
20172022202720322034
5 pending applications: term is not computable until grant.Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jun 2028 · High confidence
Also notable
Ends Jan 2033 · High confidence
Also notable
Ends Mar 2028 · High confidence
Device System and Method for Tissue Displacement or Separation
US 8,221,442
The most cited patent in this portfolio, cited by 64 later US patents, top 10% of utility patents granted in 2012 in our data. Protection runs to 2028.
Controlled Tissue Dissection Systems and Methods
US 10,201,325
The largest patent family in this portfolio, 6 related applications, renewed at 2 of 3 maintenance windows. Protection runs to 2033.
Soft Tissue Fixation Devices
US 10,987,092
Granted 2021. Computed term ends 2028.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Sep 5, 2027The maintenance fee for Controlled Tissue Dissection Systems and Methods (US 11,918,414) comes due Sep 5, 2027. Unpaid by Mar 6, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| Controlled Tissue Dissection Systems and Methods | 2 in force | to Dec 2034 |
| Delivery Device for Delivering Bioactive Agents to Internal Tissue in a Body | 1 in force | to Jul 2030 |
| Device System and Method for Tissue Displacement or Separation | 1 in force | to Jun 2028 |
| Soft Tissue Fixation Devices | 1 in force | to Mar 2028 |
Patents held now
Soonest term end first.
Showing 1 to 5 of 5
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,987,092 | Soft Tissue Fixation Devices In force · High confidence | In force | High confidence | |
| US 8,221,442 | Device System and Method for Tissue Displacement or Separation In force · High confidence | In force | High confidence | |
| US 8,480,647 | Delivery Device for Delivering Bioactive Agents to Internal Tissue in a Body In force · High confidence | In force | High confidence | |
| US 10,201,325 | Controlled Tissue Dissection Systems and Methods In force · High confidence | In force | High confidence | |
| US 11,918,414 | Controlled Tissue Dissection Systems and Methods In force · High confidence | In force | High confidence |
Also on record, not counted in the 5: 1 patent in force now held by others · 2 patents ended · 5 applications pending · 3 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.